Evidence map›Paper›PMID 41526818›Full record

ArticleBMC medical research methodology2026

Increased risk of type I errors for detecting heterogeneity of treatment effects in cluster-randomized trials using mixed-effect models.

Noorie Hyun, Abisola E Idu, Andrea J Cook, Jennifer F Bobb

Abstract read
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Noorie HyunKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Ste 1360, Seattle, WA, 98101, USA. noorie.hyun@kp.org.
Abisola E IduKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Ste 1360, Seattle, WA, 98101, USA.
Andrea J CookKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Ste 1360, Seattle, WA, 98101, USA.
Jennifer F BobbKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Ste 1360, Seattle, WA, 98101, USA.

Funding

Project-002UG1DA040314 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Ingrid A Binswanger, CYNTHIA I CAMPBELL · 2015 to 2026
$34.9M
NIDA NIH HHS UG1 DA040314NIDA NIH HHS UG1DA040314
6 · The paper itself

Abstract

BACKGROUND/

aimsEvaluating heterogeneity of treatment effects (HTE) across subgroups is common in both randomized trials and observational studies. Although several statistical challenges of HTE analyses including low statistical power and multiple comparisons are widely acknowledged, issues specific to clustered data, including cluster randomized trials (CRTs), have received less attention. For testing interactions in linear mixed-effects models (LMM), Barr et al. (2013) suggested that: random slopes for interaction terms should be studied. In this paper, we explore the impact of model misspecification, including generalized LMM (GLMM) with or without random slopes, and provide recommendations for conducting inference for HTE across subgroups in CRTs.

methodsWe conducted a simulation study to evaluate the performance of common analytic approaches for testing the presence of HTE for continuous, binary, and count outcomes: generalized linear mixed models (GLMM) and generalized estimating equations (GEE) including interaction terms between treatment and subgroup. Several simulation scenarios covered broad range of scenarios in CRTs, for example, small to a large number of clusters, small to moderate cluster-specific random slopes for subgroup. The performance metric was the empirical type I error rate compared to a nominal level. We applied the analytical methods to a real-world CRT using the count outcome utilization of healthcare from the motivating Primary Care Opioid Use Disorder treatment (PROUD) trial.

resultsWe found that standard GLMM analyses that assume a common correlation of participants within clusters can lead to severely elevated type 1 error rates of up to 47.2% compared to the 5% nominal level if the within-cluster correlation varies across subgroups. A maximal GLMM, which allows subgroup-specific within-cluster correlations, achieved the nominal type 1 error rate, as did GEE (though rates were slightly elevated even with as many as 50 clusters). Applying the methods to the real-world CRT, we found a large impact of the model specification on inference.

conclusionsWe recommend that HTE analyses using the maximal GLMM account for within-subgroup correlation to avoid anti-conservative inference. For Wald t-testing of HTE in small sample clusters, appropriate small sample correction methods should be considered based on the outcome data type.

Indexed as

Models, StatisticalRandomized Controlled Trials as TopicCluster AnalysisComputer SimulationData Interpretation, StatisticalHumansLinear ModelsResearch DesignTreatment Effect HeterogeneityCluster randomized trialsGeneralized estimating equationHeterogeneity of treatment effectsHeterogeneous correlations across subgroupsMixed-effects model

Identifiers

PMID41526818
PMCPMC12888205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.